• Wed news: BioNTech buying Biotheus. FDA’s Califf lists hopes for his successor. Amgen loses $12B market cap from hidden spreadsheet tab. TRex Bio raises $84M. London is Europe’s life science capitol. See more on our front page

Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dose

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Mar 15, 2022 at 11:02: AM
via Top executives at pandemic juggernauts Pfizer and Moderna are at odds on the need for a fourth COVID-19 vaccine dose. One says a second booster is needed “right now,” while the other thinks a fourth mRNA shot may only be essential for older adults and the immunocompromised.

article source
 




Top Bottom
Back
Quote